| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0009800 | Intron-Intron | chr3:171842992-171843228 | chr3:172125202-172125438 | 237 nt | 0.5570 |
| hsa_chr3_0365800 | Intergenic-Intergenic | chr3:171845603-171845911 | chr3:172127813-172128121 | 309 nt | 0.4498 |
| hsa_FNDC3B_0009900 | Intron-Intron | chr3:171848979-171850398 | chr3:172131189-172132608 | 1420 nt | 0.3824 |
| hsa_FNDC3B_0010600 | Intron-Exon-Intron | chr3:171851261-171871631 | chr3:172133471-172153841 | 76 nt | 0.4079 |
| hsa_FNDC3B_0010400 | Intron-Exon-Intron | chr3:171851261-171876582 | chr3:172133471-172158792 | 250 nt | 0.2720 |
| hsa_FNDC3B_0010500 | Intron-Exon-Intron | chr3:171851261-171879120 | chr3:172133471-172161330 | 250 nt | 0.2840 |
| hsa_FNDC3B_0010700 | Exon-Exon | chr3:171851261-172003774 | chr3:172133471-172285984 | 59 nt | 0.4068 |
| hsa_chr3_0365900 | Intergenic-Intergenic | chr3:171851606-171857907 | chr3:172133816-172140117 | 250 nt | 0.3400 |
| hsa_FNDC3B_0010800 | Intron-Intron | chr3:171851636-171852078 | chr3:172133846-172134288 | 443 nt | 0.4537 |
| hsa_FNDC3B_0010900 | Intron-Intron | chr3:171851826-171852137 | chr3:172134036-172134347 | 312 nt | 0.4167 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].